Anti-coagulation factor XI antibodies
US10676536B2 · kind B2 · utility
5Cited by
33References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 12, 2017 |
| Grant date | Jun 9, 2020 |
| Priority date | — |
| Expiry date | Feb 6, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.